Long-Term Functional Outcome After Early vs. Late Stoma Closure in Rectal Cancer Surgery: Sub-analysis of the Multicenter FORCE Trial
Journal of Gastrointestinal Cancer · 2024
DOI: 10.1007/s12029-024-01062-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastrointestinal Cancer, 2024. Verfasst von V M Meyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Surgery, Isala Hospitals, Dokter Van Heesweg 2, 8025 AB, Zwolle, The Netherlands. meyervi@isala.nl. Hauptthemen laut MEDLINE: Rectal Neoplasms, Quality of Life, Surgical Stomas, Fecal Incontinence. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aim of this study was to assess the effect of early stoma closure on bowel function after low anterior resection (LAR) for rectal cancer.
Methods
Patients participating in the FORCE trial who underwent LAR with protective stoma were included in this study. Patients were subdivided into an early closure group (< 3 months) and late closure group (> 3 months). Endpoints of this study were the Wexner Incontinence, low anterior resection syndrome (LARS), EORTC QLQ-CR29, and fecal incontinence quality of life (FIQL) scores at 1 year.
Results
Between 2017 and 2020, 38 patients had received a diverting stoma after LAR for rectal cancer and could be included. There was no significant difference in LARS (31 vs. 30, p = 0.63) and Wexner score (6.2 vs. 5.8, p = 0.77) between the early and late closure groups. Time to stoma closure in days was not a predictor for LARS ( R 2 = 0.001, F (1,36) = 0.049, p = 0.83) or Wexner score ( R 2 = 0.008, F (1,36) = 0.287, p = 0.60) after restored continuity. There was no significant difference between any of the FIQL domains of lifestyle, coping, depression, and embarrassment. In the EORTC QLQ-29, body image scored higher in the late closure group (21.3 vs. 1.6, p = 0.004).
Conclusion
Timing of stoma closure does not appear to affect long-term bowel function and quality of life, except for body image. To improve functional outcome, attention should be focused on other contributing factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dept of Surgery, Isala Hospitals, Dokter Van Heesweg 2, 8025 AB, Zwolle, The Netherlands. meyervi@isala.nl.
- Dept of Surgery, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands. meyervi@isala.nl.
- GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. meyervi@isala.nl.
- Dept of Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.
- Post Graduate School of Medicine (PGSOM), University Medical Center Groningen and University of Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.
- Dept of Surgery, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands.
Zitieren
APA
Meyer, V. M., Bosch, N., van der Heijden, J. A. G., Kalkdijk-Dijkstra, A. J., Pierie, J. P. E. N., Beets, G. L., Broens, P. M. A., Klarenbeek, B. R., & van Westreenen, H. L. (2024). Long-Term Functional Outcome After Early vs. Late Stoma Closure in Rectal Cancer Surgery: Sub-analysis of the Multicenter FORCE Trial. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-024-01062-2
Vancouver
Meyer VM, Bosch N, van der Heijden JAG, Kalkdijk-Dijkstra AJ, Pierie JPEN, Beets GL, et al. Long-Term Functional Outcome After Early vs. Late Stoma Closure in Rectal Cancer Surgery: Sub-analysis of the Multicenter FORCE Trial. Journal of Gastrointestinal Cancer. 2024. doi:10.1007/s12029-024-01062-2
BibTeX
@article{Meyer2024,
author = {Meyer, V M and Bosch, N and van der Heijden, J A G and Kalkdijk-Dijkstra, A J and Pierie, J P E N and Beets, G L and Broens, P M A and Klarenbeek, B R and van Westreenen, H L},
title = {Long-Term Functional Outcome After Early vs. Late Stoma Closure in Rectal Cancer Surgery: Sub-analysis of the Multicenter FORCE Trial},
journal = {Journal of Gastrointestinal Cancer},
year = {2024},
doi = {10.1007/s12029-024-01062-2}
}
EUVIMED